NSABP B-33

A randomized, placebo-controlled, double-blind trial evaluating the effect of exemestane in clinical stage T1-3 N 0-1 M0 postmenopausal breast cancer patients completing at least five years of Tamoxifen therapy.

A randomized, placebo-controlled, double-blind trial evaluating the effect of exemestane in clinical stage T1-3 N 0-1 M0 postmenopausal breast cancer patients completing at least five years of Tamoxifen therapy.